IPO Insights Unveiled

Tempest's recent IPO reveals the complexities of investing in AI-driven healthcare companies. Despite raising $1.5 billion and burning through cash, it managed to secure a market cap of $6 billion, raising questions about its valuation compared to competitors. The competitive landscape is further complicated by a patent lawsuit and the shadow of past performance from its founder's previous ventures.